Hinge Health Cash Flow Statement
NYSE: HNGETechnologyEDP ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Hinge Health free cash flow
In fiscal 2025, Hinge Health generated $171.4 million of operating cash flow and spent $708,000 on capital expenditures. That left free cash flow of $170.7 million, a free-cash-flow margin of 29.0% of revenue. Free cash flow was up 256.0% from the prior year's $48.0 million.
Hinge Health returned $65.0 million to shareholders through share repurchases, equal to 38% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Hinge Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Net Income | -528.26M | -11.93M | -108.14M |
| Net Income growth (YoY) | — | — | — |
| Depreciation & Amortization | 5.13M | 5.95M | 5.63M |
| Stock-Based Compensation | 643.01M | 739.00K | 1.65M |
| Change in Working Capital | 81.06M | 65.83M | 35.64M |
| Operating Cash Flow | 171.44M | 49.00M | -63.91M |
| Capital Expenditures | -708.00K | -1.04M | -1.98M |
| Investing Cash Flow | -113.76M | 18.31M | 1.50M |
| Share Repurchases | -65.03M | 0 | 0 |
| Financing Cash Flow | -150.47M | -2.20M | -3.00M |
| Net Change in Cash | -92.79M | 65.11M | -65.41M |
| Free Cash Flow | 170.73M | 47.96M | -65.89M |
This table shows 3 annual periods of Hinge Health's cash flow statement, from FY 2025 back to FY 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HNGE's reporting calendar. What is a cash flow statement?